Post-weaning diarrhoea, associated with the proliferation of enterotoxigenic E. coli (ETEC) in the gut, is not only a severest threat to the viability of young pigs(Reference Nagy and Fekete1), but also a threat to the health of human infants. Post-weaning diarrhoea always results in the increase of mortality, dehydration, weight loss, as well as growth retardation in young animals(Reference Rhouma, Fairbrother and Beaudry2). These disorders can be induced by various weaning stresses such as removal from the sow, abrupt changes in diet or adapting to a new environment. The histological changes in the small intestine, such as the height of villus or the depth of crypts with Paneth cells, caused by post-weaning diarrhoea may affect the immune responses of piglets and lead to an intestinal dysfunction(Reference Bhandari, Xu and Nyachoti3,Reference Burkey, Skjolaas and Minton4) . Although the utilisation of antibiotics was once considered to be the most effective measure to control ETEC infection, a growing number of countries and regions have restricted the use of antibiotics in feed to minimise the spread of strains with antibiotic resistance(Reference Owusu-Asiedu, Nyachoti and Marquardt5). The development of alternatives of antibiotics thus becomes very urgent(Reference Kiarie, Bhandari and Scott6,Reference Thacker7) . At present, the supplementation of bioactive compounds, such as oligosaccharides, seem to be a feasible way to improve weaning-related intestinal injury in post-weaned piglets(Reference Bornet, Brouns and Tashiro8,Reference Nishizawa-Yokoi, Yabuta and Shigeoka9) .
Oligosaccharides are composed of monosaccharides with low degree (2–10 glycosidic bonds) of polymerisation(Reference Le Bourgot, Ferret-Bernard and Blat10). Fructo-oligosaccharides (FOS) are composed of fructose and glucose units, specifically referring to a short chain of fructose units (3–6) connected by β-(2–1) bonds to the terminal glucose units(Reference Sabater-Molina, Larqué and Torrella11). Such chemical structure of FOS makes it unable to be directly digested by animals but can be fermented by various micro-organisms in the large intestine of pigs(Reference Schokker, Fledderus and Jansen12). The utilisation of FOS by gut microbes may be beneficial to the resistance against pathogen infection, oxidative stress, mutagenicity and even the occurrence and development of colon cancer(Reference Sabater-Molina, Larqué and Torrella11–Reference Gao, Jiang and Zhou13), which makes FOS become an attractive alternative of antibiotics in swine feed.
As the largest immune organ in animal body, gastrointestinal tract plays a vital role in activating the innate immunity and inducing the subsequent adaptive immune responses(Reference Oswald14,Reference Pié, Lallès and Blazy15) . ETEC is one of the main pathogens leading to the symptomatic gastroenteritis in human infants and young animals(Reference Kiarie, Bhandari and Scott6). Once ETEC or its toxins enter into blood through the damaged intestinal epithelium, the general immune response is induced and the immune cells in tissues are activated by the recognition of bacterial ligands, resulting in a rapid burst of pro-inflammatory cytokines and the dysfunction of gastrointestinal tract(Reference Nyachoti, Kiarie and Bhandari16,Reference Bosi, Casini and Finamore17) . Since FOS may be beneficial for improving the intestinal health in animals, several studies have been focused on its effect on the intestinal environment and immunological activity of weaned pigs(Reference Csernus and Czeglédi18) which are vulnerable to the early-life stress due to the underdeveloped gastrointestinal tract and immune system, but the influence of FOS on the intestinal permeability, intestinal barrier, or even the apoptosis of intestinal epithelial cells still remains to be discussed. Therefore, a piglet model with ETEC infection was built in the current study to comprehensively investigate the effect of dietary FOS supplementation on the growth performance, inflammatory responses, function of intestinal epithelium, and antioxidative capacity in weaned piglets. Moreover, pigs share similar anatomic and physiological structures with humans(Reference Kraemer, Ramette and Aebi19), and our results may also provide convincing evidence on the possible prebiotic effect of FOS and offer key insights into the underlying mechanisms.
Materials and methods
Animal trial
All the procedures used in the animal experiment were approved by the Institutional Animal Care and Use Committee of Sichuan Agricultural University. The animal experimental design of the current study has been reported before(Reference Liu, Chen and Yu20). In brief, twenty-four healthy 21-d-old weaned crossbred (Duroc × Landrace × Yorkshire) pigs with an average initial body weight of 6·49 kg were selected and randomly divided into three groups after a 3-d adaptation, including: (1) non-ETEC-challenged control (CON; pigs fed a basal diet and infused with sterilised Luria–Bertani culture); (2) ETEC-challenged control (ECON; pigs fed a basal diet and infused with active ETEC); and (3) ETEC challenge + FOS treatment (EFOS; pigs fed a basal diet supplemented with 2·5 g/kg FOS and infused with active ETEC). The FOS (≥ 20 %) used in the current study, purchased from Shanghai Lanpu Biotechnology CO., LTD, is the fructosyltransferase hydrolysate of chicory. The FOS product is a series of oligosaccharides with 2–10 degree of polymerisation, which is composed of glucose and fructose units bound together by β-1, 2 glycosidic bonds in a ratio of 1:2·5. The carrier of the FOS product is maize starch. The basal diet (online Supplementary Table 1) was formulated to meet the nutrient requirements recommended by the National Research Council(21). Each group consisted of eight pigs and each pig was individually housed in a metabolic cage (0·7 m × 1·5 m). Pigs were allowed access to food and water ad libitum with room temperature maintained at 25–28°C and relatively controlled humidity (55–65 %). The trial lasted for 21 d, and the FOS treatment was applied in the whole experimental period. On day 19, pigs in the ECON and EFOS groups were orally administered with 150 ml of Luria–Bertani culture containing active ETEC (2·5 × 109 CFU/ml, serotype O149: K91: K88ac; China Institute of Veterinary Drugs Control), while pigs in the CON group were orally administered with an equal volume of sterilised Luria–Bertani culture(Reference Xiao, Wang and Liu22). The feed intake of each pig was measured daily, and the body weight of each pig was measured on day 22 after 12-h fasting. The gain-to-feed ratio of each pig was calculated according to the average daily gain and average daily feed intake.
Collection of blood and tissue samples
In the early morning of day 22, approximate 10 ml of jugular vein blood of each pig was collected into a centrifuge tube with heparin Na anticoagulant by venepuncture after 12 h of fasting, and the blood sample was centrifuged at 3500 × g at 4°C for 10 min to obtain plasma(Reference Bradford23). All the prepared plasma samples were kept at −20°C until analysis. After the collection of blood sample, each pig was euthanised with an intravenous injection of Na pentobarbital at a dosage of 200 mg/kg body weight and then slaughtered(Reference Liu, Wu and Chen24), and the abdomen was opened rapidly. Approximately, 2 cm of each middle duodenum, jejunum and ileum was separated with sterile surgical scissors and fixed in 4 % paraformaldehyde solution for the immunofluorescence detection. Finally, the duodenal, jejunal and ileal mucosa of each pig was collected using a scalpel blade and stored at −80°C for the analysis of antioxidant capacity and gene expression.
Detection of intestinal antioxidant capacity and cytokines
Plasma antioxidant enzymes such as the catalase (CAT) and GSH, malondialdehyde (MDA), and the total antioxidant capacity (T-AOC) were measured by using commercial kits purchased from Nanjing Jiancheng Bioengineering Institute. The activity of diamine oxidase (DAO) in the plasma was also measured by using commercial kits purchased from Nanjing Jiancheng Bioengineering Institute. The concentrations of inflammatory cytokines such TNF-α, IL-1β and IL-6 in the intestinal mucosa were detected by using an ELISA following the instructions of corresponding kits supplied by Jiangsu Jingmei Biotechnology Co., Ltd. All the above kits are swine-specific. The minimum detectable concentrations of DAO, TNF-α, IL-1β and IL-6 are 10 pg/m, 10 pg/ml, ng/l and 50 ng/l, respectively. In addition, the minimum detectable concentrations of CAT, GSH, MDA and T-AOC are 0·2 U/ml, 20 mg/ml, 0·5 nmol/ml and 0·2 U/ml, respectively.
Immunofluorescence analysis and real-time PCR analysis
The localisation of zonula occluden-1 (ZO-1) protein, one of the tight junction proteins, in the duodenum, jejunum and ileum of each pig was determined using immunofluorescence according to our described method(Reference Wan, Zhang and Chen25). The fluorescence of each slide was investigated using a confocal scanning microscope (NIKON ECLIPSE TI-SR), and the images were analysed using the NIKON DS-U3 software. The total RNA of duodenal, jejunal and ileal mucosa from each pig was extracted using the Trizol Reagent (TaKaRa). The concentration and purity of the extracted RNA sample were assayed with a spectrophotometer (Nano Drop, Gene Company Limited) at 260 and 280 nm. The ratio of optical density (OD) 260/280 should vary between 1·8 and 2·0. The reverse transcription of each RNA sample was performed using the Prime Scripte RT reagent kit (TaKaRa Biotechnology) following the manufacturer’s instructions. The primers (online Supplementary Table 2) for genes, toll-like receptor 4 (TRL-4), NF-κB, myeloid differentiation factor 88 (MYD88), nuclear factor-erythroid 2 (Nrf2), haem oxygenase-1 (HO-1), cysteinyl aspartate-specific proteinase-3 (Caspase-3), B-cell lymphoma-2 (BCL-2), BCL-2-associated x protein (Bax) and porcine β-defensin 1 (pBD129), were synthesised commercially by Takara Bio Inc.. Real-time PCR was conducted using the CFX-96 real-time PCR detection system (Bio-Rad). The reaction procedures and the preparation of reaction mixture system have been described before(Reference Wan, Zhang and Chen25). The mRNA level of the target genes was calculated using the 2–ΔΔCt method(Reference Livak and Schmittgen26), and three replicates for each sample were simultaneously performed.
Flow cytometry assays
The percentage of cell apoptosis in the jejunum of each pig was determined by flow cytometry. In detail, the intestinal sample of each pig was flushed gently with ice-cold PBS (for 1-litre: 8·00 g NaCl, 0·20 g KCl, 1·78 g Na2HPO4·2 H2O, 0·27 g KH2PO4, pH 7·4), and the washed intestinal serosa layer was spread on a sterile ice pack. The mucosal cells were then scraped with a glass slide. After adding moderate Roswell Park Memorial Institute (RPMI) 1640 medium (Hyclone), the cells were transferred to a new centrifuge tube and mixed using a vortex mixer. The mixed cells were then filtered into a flow tube with a 300-mesh filter cloth and centrifuged at 300 × g for 5 min. Then the supernatant was discarded and the sediment was washed again with PBS. The cells were resuspended with 200 µl of Binding Buffer (10 mm 2-[4-(2-hydroxyethyl)-1-piperazinyl] ethanesulfonic acid, 140 mm NaCl, 2·5 mm CaCl2, pH 7·4), and the concentration of the cells was adjusted to 106 cells/ml with PBS at 4°C. Finally, approximate 100 μl of the cell suspension was taken into a flow tube and then resuspend with 1 ml of Binding Buffer and centrifuged at 300 × g for 5 min to obtain sediment. To detect the apoptosis rate of the cells, 5 μl of Annexin V-FITC (fluorescein isothiocyanate, Invitrogen) was added into the tube for fluorescence staining (10 min), and then another 5 μl of propidium iodide staining solution was applied into the tube for 5 min. After the incubation with 500 μl of Binding Buffer, the number of apoptosis cells was detected by CytoFLEX flow cytometry (Backman) and the data were analysed using the CytExpert software (Backman).
Statistical analysis
All data were subjected to one-way ANOVA for a completely randomised design using the general linear model procedure of Statistical Product and Service Solutions (SPSS) 24.0 (SPSS, Inc.). Statistical differences among treatments were separated by Tukey’s multiple-range test. The results were shown as means and standard error of means. The difference between groups was regarded as significant when P < 0·05, and a trend in difference was regarded when 0·05 < P < 0·10.
Results
Effect of fructo-oligosaccharide supplementation on growth performance and antioxidant capacity in weaned piglets upon enterotoxigenic E. coli challenge
There were no differences (P > 0·05, Table 1) in the average daily gain, average daily feed intake and gain-to-feed ratio of pigs among the three groups throughout the experimental period. Compared with CON pigs, ETEC challenge decreased the activity of GSH peroxidase (GSH-Px) and CAT and increased the concentration of MDA in the plasma (P < 0·05, Table 2). However, the activity of GSH-Px and CAT was increased and the concentration of MDA was decreased (P < 0·05, Table 2) in the plasma of EFOS pigs when compared with ECON pigs, and the value of these parameters showed no differences between CON and EFOS pigs (P > 0·05, Table 2).
Growth performance of pigs from the three experimental groups (Mean values and their standard errors of the mean, n 8)
CON, non-ETEC-challenged control; ECON, ETEC-challenged control; EFOPS, ETEC challenge + FOS treatment; BW, body weight; ADFI, average daily feed intake; ADG, average daily gain; F:G, ADFI/ADG.
All the measured growth performance-related parameters are for whole experimental period (1–21 d).
Non-challenged pigs (CON, fed with basal diet), ETEC-challenged pigs (ECON, fed with basal diet and challenged by ETEC), and FOS- and ETEC-treated pigs (EFOS, fed with basal diet containing 2.5 g/kg FOS and challenged by ETEC).
Improvement of parameters related to antioxidant capacity in the plasma of ETEC-challenged piglets by FOS supplement (Mean values and their standard errors of the mean, n 8)
ETEC, enterotoxigenic E. coli; FOS, FOS, fructo-oligosaccharides; CON, non-ETEC-challenged control; ECON, ETEC-challenged control; EFOPS, ETEC challenge + FOS treatment; SOD, superoxide dismutase; GSH-Px, GSH peroxidase; T-AOC, total antioxidant capacity, MDA, malondialdehyde; CAT, catalase; DAO, diamine oxidase.
a,b,cDiverse superscript letters in the same row mean significant differences (P < 0 05).
Non-challenged pigs (CON, fed with basal diet), ETEC-challenged pigs (ECON, fed with basal diet and challenged by ETEC), and FOS- and ETEC-treated pigs (EFOS, fed with basal diet containing 2.5 g/kg FOS and challenged by ETEC).
Effect of fructo-oligosaccharide supplementation on intestinal permeability and the distribution of zonula occluden-1
Compared with the CON pigs, the concentration of plasma DAO was elevated in ECON pigs (P < 0·05), while it was recovered in EFOS pigs (P > 0·05, Table 2). Importantly, result of immunofluorescence analysis showed that the localisation of ZO-1 in the duodenum was not affected by dietary FOS. In the jejunum and ileum of ECON pigs, the staining of ZO-1 was diffuse with little staining at the intercellular tight junction region, which was improved in EFOS pigs (Fig. 1a). Further analysis showed that the fluorescence intensities of ZO-1 in the duodenum and jejunum of ECON pigs were lower than that of ECON and EFOS pigs (Fig. 1b).
Effect of dietary FOS supplement on the distribution and localisation of ZO-1 in the intestinal epithelium of pigs in different groups revealed by immunofluorescence. ZO-1 protein (green), DAPI stain (blue) as well as merged ZO-1 protein and DAPI are presented. Non-challenged pigs (CON, fed with basal diet), ETEC-challenged pigs (ECON, fed with basal diet and challenged by ETEC), and FOS- and ETEC-treated pigs (EFOS, fed with basal diet containing 2·5 g/kg FOS and challenged by ETEC). (a) Immunofluorescence image of duodenum, jejunum and ileum. (b) Fluorescence intensity analysis corresponding to each intestinal segment. ETEC, enterotoxigenic E. coli; FOS, fructo-oligosaccharides; ZO-1, zonula occluden-1.
Effect of fructo-oligosaccharide supplementation on cell apoptosis in intestinal mucosa
Result of flow cytometry showed an increase (P < 0·05) of the early-stage, late-stage and total apoptosis rate in the jejunum of ECON pigs compared with CON pigs, which was reduced (P < 0·05) in EFOS pigs compared with ECON pigs (Fig. 2).
Effect of dietary FOS supplement on the apoptosis rate of IEC in the jejunum of pigs in different groups revealed by flow cytometry. (a and d) Percentage of apoptotic cells at early stage of apoptosis. (b and e) Percentage of apoptotic cells at late stage of apoptosis. (d and f) The total apoptosis rate. (a, b and c) [A] means a total of 30 000 cells were used in each acquisition reading. Frames were divided into four quadrants: B-+ represents necrotic cells, B++ represents late apoptotic and early necrotic cells, B-- represents early apoptotic cells, and B+- represents normal cells. Non-challenged pigs (CON, fed with basal diet), ETEC-challenged pigs (ECON, fed with basal diet and challenged by ETEC), and FOS- and ETEC-treated pigs (EFOS, fed with basal diet containing 2·5 g/kg FOS and challenged by ETEC). a,b,cDiverse superscript letters on top of each bar mean significant differences (P < 0·05). ETEC, enterotoxigenic E. coli; FOS, fructo-oligosaccharides; IEC, intestinal epithelial cells.
Effect of fructo-oligosaccharide supplementation on intestinal mucosa immunity
The content of TNF-α in the small intestinal mucosa, IL-1β in the jejunal and ileal mucosa, and IL-6 in the duodenal and ileal mucosa of ECON pigs showed elevated compared with CON pigs (P < 0·05, Fig. 3), while FOS supplementation decreased the contents of TNF-α and IL-1β in the intestinal mucosa of pigs challenged by ETEC when compared with ECON pigs (P < 0·05).
Effect of dietary FOS supplement on the concentration of cytokines in the mucosa of small intestine of pigs in different groups revealed by real-time PCR. TNF-α (A), IL-1β (B), IL-6 (C). Non-challenged pigs (CON, fed with basal diet), ETEC-challenged pigs (ECON, fed with basal diet and challenged by ETEC), and FOS- and ETEC-treated pigs (EFOS, fed with basal diet containing 2·5 g/kg FOS and challenged by ETEC). a,b,cDiverse superscript letters on top of each bar mean significant differences (P < 0·05). ETEC, enterotoxigenic E. coli; FOS, fructo-oligosaccharides.
Effect of fructo-oligosaccharide supplementation on the mucosal antioxidant capacity
Compared with CON and EFOS pigs, the concentration of MDA in the duodenal mucosa of ECON pigs was higher (P < 0·05, Table 3). Meanwhile, the activities of CAT, GSH-Px and superoxide dismutase in the jejunum mucosa as well as the activities of GSH-Px and superoxide dismutase in the ileum mucosa of ECON pigs were decreased compared with CON pigs (P < 0·05), which were improved in EFOS pigs (P < 0·05).
Improvement of parameters related to antioxidant capacity in small intestine of ETEC-challenged piglets by FOS supplement
(Mean values and their standard errors of the mean)
ETEC, enterotoxigenic E. coli; FOS, FOS, fructo-oligosaccharides; CON, non-ETEC-challenged control; ECON, ETEC-challenged control; EFOPS, ETEC challenge + FOS treatment; CAT, catalase; MDA, malondialdehyde; GSH-Px, GSH peroxidase; T-AOC, total antioxidant capacity; SOD, superoxide dismutase.
a,b,cDiverse superscript letters in the same row mean significant differences (P < 0.05).
Data are shown as means and sem, n 8.
Non-challenged pigs (CON, fed with basal diet), ETEC-challenged pigs (ECON, fed with basal diet and challenged by ETEC), and FOS- and ETEC-treated pigs (EFOS, fed with basal diet containing 2.5 g/kg FOS and challenged by ETEC).
Effect of fructo-oligosaccharide supplementation on the expressions of critical genes related to intestinal epithelium integrity
ETEC challenge upregulated the expressions of critical inflammation-related genes such as the TLR-4 and MYD88 in the jejunal mucosa (Fig. 4). However, FOS supplementation decreased their expressions in the jejunual mucosa (P < 0·05). Moreover, FOS supplementation decreased the expressions of TLR-4 and NF-kB in the duodenal and ileal mucosa, respectively (P < 0·05) but elevated the expression of pBD-129 in the duodenual and ileal mucosa (P < 0·05). The expression of antioxidant genes, such as the Nrf-2 in the jejunum and HO-1 in the ileum, were higher in EFOS pigs than that in other pigs when compared with ECON pigs (P < 0·05). FOS supplementation also elevated the expression of BCL-2 but decreased the expression of Caspase-3 in the jejunual mucosa (P < 0·05).
Effect of dietary FOS supplement on the relative expression of genes associated with inflammation, antioxidant capacity and apoptosis in the mucosa of small intestine of pigs in different groups. Non-challenged pigs (CON, fed with basal diet), ETEC-challenged pigs (ECON, fed with basal diet and challenged by ETEC), and FOS- and ETEC-treated pigs (EFOS, fed with basal diet containing 2·5 g/kg FOS and challenged by ETEC). a,b,cDiverse superscript letters on top of each bar mean significant differences (P < 0·05). ETEC, enterotoxigenic E. coli; FOS, fructo-oligosaccharides; TLR4, toll-like receptor 4; MyD88, myeloid differentiation factor 88; Nrf2, nuclear factor erythroid-derived 2-related factor 2; HO-1, haem oxygenase-1; BAX, B-cell lymphoma-2-associated X protein; BCL-2, B-cell lymphoma-2; Caspase-3, cysteinyl aspartate-specific proteinase-3.
Discussion
Post-weaning diarrhoea caused by ETEC infection brings great economic loss to swine industry. In the present study, we proved that the short-term (21 d) supplement of FOS in the diet did not affect the growth performance of weaned pigs and showed the protective effect of FOS against ETEC-induced intestinal injury in these animals, confirming the potential of FOS as a new healthy feed additive for post-weaning pigs.
Oxidative stress is a prerequisite condition of inflammatory responses. Excessive free radicals are harmful and scavenged by the antioxidant system including non-enzymatic components or a series of antioxidant enzymes(Reference Bolzán, Bianchi and Bianchi27,Reference Lightfoot, Skibola and Smith28) . In the present study, dietary supplementation of FOS was found to maintain the activity of CAT and the concentration of GSH-Px in both plasma and intestinal mucosa of weaned piglets subject to the challenge of ETEC. Consistent results were also found on the mRNA level of Nrf2 and HO-1 genes in the intestinal mucosa of these animals. Nrf2 is a well-known critical transcription factor that can regulate the expression of genes involved in the production of a wide variety of antioxidant enzymes (i.e. GSH-Px and CAT), as well as those genes related to detoxification or ‘stress-response’(Reference Yang, Ferket and Hong29). HO-1 is one of the most important target genes of Nrf2, which can catalyse the rate-limiting step in the degradation of haem and produce free Fe, biliverdin and carbon monoxide(Reference Kim, Pae and Park30). Our findings suggest that the dietary supplementation of FOS may contribute to restore the reduced antioxidant capacity of piglets when encountering ETEC infection.
ETEC infection is usually characterised by extensive production of enterotoxins which is easy to penetrate the blood through the damaged intestinal epithelium(Reference Luo, Kumar and Vickers31–Reference Tang, Tan and Xiong33). The intestinal barrier is composed of a layer of columnar epithelium and interepithelial tight junctions, a highly dynamic barrier structure that can selectively absorb water, ions and nutrients by adjusting the permeability among cells, playing a great role in the defence and immunity of the gastrointestinal tract(Reference Dokladny, Zuhl and Moseley34). In the current study, we found that the expression of ZO-1 protein, the most important tight junction(Reference Fanning, Jameson and Jesaitis35), was substantially decreased in the apical region of the epithelial cells in small intestine of the piglets by the ETEC challenge. However, the expression of ZO-1 in the small intestine of pigs fed FOS-containing diet showed no difference compared with those healthy controls even if exposed to ETEC attack, indicating a possible protection of FOS on the intestinal barrier. As a highly active intracellular enzyme in the cytoplasm of intestinal mucosal upper villi, DAO is concentrated and has strong activity in the intestinal mucosal upper villi but is less abundant and has very low activity in other tissues(Reference Maria Paola and Autuori36). When the intestinal mucosa is damaged, the intracellular DAO is released into the blood, leading to a sharp rise of DAO in the blood, which makes the activity of DAO a marker to evaluate the integrity and permeability of intestinal epithelium in the case of pathogenic infections(Reference Thompson, Vaughan and Forst37). Here, we showed that ETEC challenge significantly elevated the concentrations of DAO in the plasma of weaned pigs, indicating a disruption of the intestinal epithelial barrier in these animals. Conversely, when FOS was supplemented into the diet, the concentration of DAO in the plasma of piglets was not affected even under the attack of ETEC, showing a noticeable protection of dietary FOS.
Intestinal epithelial cells (IEC) are in a state of continuous proliferation and renewal(Reference Vereecke, Beyaert and van Loo38). During this homoeostasis, apoptosis is beneficial to the regeneration and repair of IEC, and the interaction among the proliferation, renewal and apoptosis of IEC is responsible for the normal function of intestinal barrier(Reference Fujimoto, Iwakiri and Wu39,Reference Bernstein, Holubec and Warneke40) . Yet, the excessive apoptosis of IEC leads to the abnormal increase of intestinal permeability and the dysfunction of intestinal barrier, as well as the subsequent diarrhoea(Reference Souza, Tortori and Castelo-Branco41). ETEC infection has been proved to promote the apoptosis of IEC in vitro and in vivo (Reference Ren, Yin and Chen42,Reference Xia, Bin and Liu43) . In the current study, we confirmed that the challenge of ETEC increased the apoptosis rate of the jejunal epithelial cells of weaned pigs. Interestingly, the apoptosis rate of these cells in ETEC-infected piglets was reduced to normal level by the pre-feeding of FOS-containing diet. Theoretically, the apoptosis of IEC involves the activation of multiple proteins and genes. Of these proteins, Bcl-2 is found to specifically inhibit the expression of apoptotic proteins in the interstitial space and maintain the integrity of the mitochondrial membrane through binding to Bid, Bim or Bad and separating from Bax or Bak. It can also directly combine with the active factor of apoptotic protein-1 (Apaf-1) to form the Bcl-2/Apaf-1/Caspase-9 complex, blocking the initial activation of caspase, a family of common downstream effectors of multiple apoptosis pathways(Reference Neuzil, Wang and Dong44,Reference Yuan, Liu and Yao45) . The protease cascade reaction is the only way to directly induce the apoptosis of IEC in pigs(Reference Budihardjo, Oliver and Lutter46,Reference Riedl and Shi47) . In the present study, we found that the ETEC challenge increased the mRNA level of the apoptosis-related marker gene, Caspase-3, in the small intestine of weaned piglets. But the pre-supplementation of FOS in the diet can prevent this increase of Caspase-3 and simultaneously enhance the expression of the two apoptosis repression-related marker genes, Bcl-2 and BAX, especially in the jejunum. These results provide a molecular basis for the interpretation of improved apoptosis of IEC in those pigs pre-fed with FOS-containing diet.
During the development of intestinal inflammation caused by infectious pathogens, the activation of TLR4/NF-κB signalling pathway is regarded as a key incentive(Reference Sabroe, Parker and Dower48). As a typical pattern recognition receptor existing in intestinal epithelium, activated TLR4 can stimulate the activation of MyD88/NF-κB signalling pathway, leading to the release of various inflammatory cytokines, such as IL-6, TNF-α and IL-1. On the other hand, some self-produced molecules, such as β-defensins, can directly help IEC themselves fight against pathogens by killing microbes and activating inflammatory cells located in the infected site(Reference Pomorska-Mo and Markowska-Daniel49). We found that the pre-feeding of dietary FOS can reduce the concentration of TNF-α, IL-6 and IL-1β in the mucosa of small intestine of ETEC-infected pigs to normal level, and such pre-feeding can even increase the expression of pBD129 gene in the duodenum and ileum of these pigs to a level far higher than that of uninfected pigs. Similarly, when the maternal diet is supplemented with short-chain FOS at 3·3 g/kg during the last 4 weeks of gestation and 1·5 g/kg during the lactation, the TNF-α expression decreases in the visceral adipose tissue of their piglets(Reference Le Bourgot, Ferret-Bernard and Apper50). And the short-chain FOS supplementation in the diet at 0·15 % also reduces the concentration of TNF-α in the ileum of post-weaning pigs(Reference Le Bourgot, Le Normand and Formal51). The further real-time PCR analysis also indicates that the decreased expression of inflammatory cytokines in the small intestine of these ETEC-infected pigs pre-fed may probably be achieved by the inhibition of TLR4/MyD88/NF-κB pathway. Previous studies also show similar mechanism of mannan-oligosaccharide and galacto-oligosaccharides inhibiting the inflammation in weaning pigs and human infants(Reference Scholtens, Alliet and Raes52,Reference Che, Song and Liu53) .
Conclusions
Our findings suggest that the dietary supplementation of FOS can attenuate the disruption of the intestinal mucosa caused by ETEC in weaned piglets, which was associated with the increase in antioxidative capacity and the improvement of intestinal barrier functions. These beneficial effects of FOS on the intestinal health make it an attractive prebiotic that can be tentatively used in the diet of young animals.
Acknowledgements
The authors thank Wang Huifen, Wu Fali and Yu En for their help during the animal trial and sample collections.
This work was supported by the Key Research and Development Programs of Sichuan Province (20ZDYF0003 and 2018NZDZX0005), and the National Natural Science Foundation of China (31972599).
Y. L., L. L. and J. H. conceived the study, performed the experiment, performed data analysis and contributed to drafting the manuscript. L. L. carried out the animal experiment. D. C., B. Y., Z. H., P. Z., X. M., J. Y., J. L. and H. Y. conceived the experiment and proofread the manuscript. All authors read and approved the final manuscript.
The authors declare that there are no conflicts of interest.
Supplementary material
For supplementary material/s referred to in this article, please visit https://doi.org/10.1017/S0007114521004451
